Herantis Pharma Announces Expansion of its Phase 2 Study AdeLE in Breast Cancer Associated Lymphedema with Two Centers in Sweden
Herantis Pharma Announces Expansion of its Phase 2 Study AdeLE in Breast Cancer Associated Lymphedema with Two Centers in Sweden Herantis Pharma PlcCompany release 28 March 2019 at 9:00 am Herantis Pharma Plc (“Herantis”) announced today the expansion of its Phase 2 AdeLE clinical trial in Sweden to include the Karolinska University Hospital in Stockholm, and the Uppsala University Hospital. The AdeLE study will also continue to recruit patients at three university hospitals in Finland. “As two of the largest and most renown clinical centers in Sweden, it is very positive for our